1214900-01-2 Usage
Description
2-(Benzyloxy)pyridin-4-aMine is an organic compound characterized by its unique chemical structure, which features a pyridine ring with a benzyloxy group at the 2nd position and an amine group at the 4th position. 2-(Benzyloxy)pyridin-4-aMine is known for its potential applications in the pharmaceutical and chemical industries due to its versatile chemical properties.
Uses
Used in Pharmaceutical Industry:
2-(Benzyloxy)pyridin-4-aMine is used as a key intermediate in the synthesis of nicotinamide derivatives, which are known as Syk inhibitors. These inhibitors play a crucial role in modulating various biological processes and have potential therapeutic applications in treating conditions such as autoimmune disorders, inflammatory diseases, and certain types of cancer.
Used in Chemical Industry:
In the chemical industry, 2-(Benzyloxy)pyridin-4-aMine can be utilized as a building block for the development of various complex organic molecules and pharmaceutical compounds. Its unique structure allows for further functionalization and modification, making it a valuable asset in the synthesis of novel molecules with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 1214900-01-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,4,9,0 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1214900-01:
(9*1)+(8*2)+(7*1)+(6*4)+(5*9)+(4*0)+(3*0)+(2*0)+(1*1)=102
102 % 10 = 2
So 1214900-01-2 is a valid CAS Registry Number.
1214900-01-2Relevant articles and documents
NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF
-
Paragraph 0881; 0882; 0886, (2018/09/08)
An object of the present invention is to provide to a compound and a pharmaceutical composition, which have excellent Syk-inhibitory activity. Th e present invention provides a nicotinamide derivative represented by the follo wing formula (I) (wherein R 1 represents a halogen atom; R 2 represents a C 1-12 alkyl group, a C 2-12 alkenyl group, a C 2-12 alkynyl group, a C 3-8 cycloalkyl g roup, an aryl group, an ar-C 1-6 alkyl group or a heterocyclic group, each opti onally having at least one substituent; R 3 represents an aryl group or a hetero cyclic group each optionally having at least one substituent; and R 4 and R 5 e ach independently represent a hydrogen atom; and R 2 and R 4 may form a cyc lic amino group optionally having at least one substituent together with the ni trogen atom to which they bind) or a salt thereof, and a pharmaceutical comp osition for use in the treatment of a Syk-related disease which comprises the nicotinamide derivative or a salt thereof.
